Showing 13,641 - 13,660 results of 23,519 for search '(( 5 ((wt decrease) OR (nn decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.81s Refine Results
  1. 13641

    Statistical comparisons for the joint entropy measurements obtained from individual subjectspresented in Tables 1–3. by Vladímir de Aquino Silveira (513285)

    Published 2014
    “…In all frequencies there was a trend for joint entropy to decrease when contrast was increased, but this reached the level of statistical significance only for the comparison between 5% and 100% contrasts (p<0.05; One-Way ANOVA, Tukey Multiple Comparison Test). …”
  2. 13642

    Percent change in production and consumption sustainability for the top 25 seafood producing countries (according to FAO data). by Kayla M. Blincow (20370884)

    Published 2024
    “…The nature of this equation means that positive percent change values occur for countries that have a decrease in consumption sustainability compared to production sustainability and negative values occur for countries that have an increase.…”
  3. 13643

    DataSheet1_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.zip by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  4. 13644

    Image4_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  5. 13645

    Image3_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.JPEG by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  6. 13646

    Image6_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  7. 13647

    Image8_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  8. 13648

    Image9_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  9. 13649

    Image5_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  10. 13650

    Image7_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  11. 13651

    Image11_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  12. 13652

    Image10_SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.TIF by Ruixue Guo (6377939)

    Published 2022
    “…Additionally, SGLT2, IGF1R, phosphorylated PI3K, α-SMA, SNAI-1, and ZEB2 protein levels were increased in high glucose-stimulated human podocytes (HPC) and significantly decreased in dapagliflozin-treated (50 nM and 100 nM) or OSI-906-treated (inhibitor of IGF1R, 60 nM) groups. …”
  13. 13653

    Table_2_Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease.pdf by Shreaya Chakroborty (292318)

    Published 2020
    “…Compared to WT controls, MSNs recorded in TG5 animals exhibited decreased spike probability during cortical stimulation delivered at low to moderate stimulation intensities. …”
  14. 13654

    Table_1_Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease.pdf by Shreaya Chakroborty (292318)

    Published 2020
    “…Compared to WT controls, MSNs recorded in TG5 animals exhibited decreased spike probability during cortical stimulation delivered at low to moderate stimulation intensities. …”
  15. 13655

    Hh signaling interacts with NB temporal cascade component. by Phing Chian Chai (382425)

    Published 2013
    “…(K) Quantification of GMC numbers in various mutant backgrounds. A typical <i>wt</i> NB clone contained three to five GMC-like cells which are Dpn- and Elav-negative. …”
  16. 13656

    Data Sheet 1_Reduction of orexin-expressing neurons and a unique sleep phenotype in the Tg-SwDI mouse model of Alzheimer’s disease.pdf by Yan Wu (70890)

    Published 2025
    “…We performed a sleep study on Tg-SwDI mice, a cerebral amyloid angiopathy (CAA) model, and age-matched wild-type (WT) control mice. The results showed that at 12 months of age, the hemizygous Tg-SwDI mice spent significantly more time in non-rapid eye movement (NREM) sleep (44.6 ± 2.4% in Tg-SwDI versus 35.9 ± 2.5% in WT) and had a much shorter average length of wake bout during the dark (active) phase (148.5 ± 8.7 s in the Tg-SwDI versus 203.6 ± 13.0 s in WT). …”
  17. 13657

    hMSCs inhibit TNF-α secretion from macrophage-like cells more efficiently in the presence of IFN-γ. by Mika Pietilä (332438)

    Published 2013
    “…<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031671#s3" target="_blank">Results</a> are represented as a mean±SD of co-cultures of eight different hMSC lines. …”
  18. 13658

    Effect of ELAP fractions on apoptotic markers in HepG2 cells. by Daleya Abdulaziz Bardi (560119)

    Published 2014
    “…Isolated fractions caused a marked elevation in cytochrome <i>c</i> release and cell membrane permeability, and a noticeable decrease in MMP. …”
  19. 13659

    Comparison of tuned response amplitude with the same contrast in mixed and in constant contrast blocks. by Lionel G. Nowak (373941)

    Published 2013
    “…Relative to 100%, the distribution for high contrast is shifted to the left, indicating that response amplitude was larger for high contrast when neurons were adapted to a mixture of contrasts, compared to when neurons were adapted to the high contrast. …”
  20. 13660

    miR-9 directly interacted with the putative binding sites in the 3′-UTR of cyclin D1 and Ets1. by Liduan Zheng (182440)

    Published 2013
    “…The symbols (* and #) indicate a significant decrease and a significant increase from mock or anti-NC, respectively.…”